Overview
Zhenya Hong practices in Wuhan, China. Hong is rated as an Experienced expert by MediFind in the treatment of Multiple Myeloma. Their top areas of expertise are Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), and Factor 13 Deficiency.
Their clinical research consists of co-authoring 41 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- B-Cell LymphomaHong isExperienced. Learn about B-Cell Lymphoma.
- Blood ClotsHong isExperienced. Learn about Blood Clots.
- Childhood Acute Myeloid Leukemia
- Chronic Myelogenous Leukemia (CML)
- Chronic Myelomonocytic Leukemia (CMML)
- Congenital AfibrinogenemiaHong isExperienced. Learn about Congenital Afibrinogenemia.